Virtus ETF Advisers LLC Cytom X Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.53 - $2.89 $39,220 - $74,082	-25,634 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.67 - $4.68 $4,047 - $7,094	-1,516 Reduced 5.58%	25,634 $68,000
Q4 2021 Feb 14, 2022	SELL	$3.87 - $7.39 $8,544 - $16,317	-2,208 Reduced 7.52%	27,150 $118,000
Q3 2021 Nov 15, 2021	SELL	$4.32 - $6.43 $6,644 - $9,889	-1,538 Reduced 4.98%	29,358 $149,000
Q2 2021 Aug 10, 2021	SELL	$6.33 - $9.91 $45,101 - $70,608	-7,125 Reduced 18.74%	30,896 $196,000
Q1 2021 May 17, 2021	BUY	$6.6 - $9.0 $4,474 - $6,102	678 Added 1.82%	38,021 $294,000
Q4 2020 Feb 12, 2021	SELL	$6.47 - $7.9 $8,915 - $10,886	-1,378 Reduced 3.56%	37,343 $245,000
Q3 2020 Nov 13, 2020	SELL	$6.55 - $8.83 $34,616 - $46,666	-5,285 Reduced 12.01%	38,721 $257,000
Q2 2020 Aug 05, 2020	SELL	$7.4 - $14.64 $46,028 - $91,060	-6,220 Reduced 12.38%	44,006 $367,000
Q1 2020 May 14, 2020	SELL	$3.61 - $8.6 $26,392 - $62,874	-7,311 Reduced 12.71%	50,226 $385,000
Q4 2019 Feb 13, 2020	BUY	$5.17 - $8.91 $171,830 - $296,132	33,236 Added 136.77%	57,537 $478,000
Q3 2019 Nov 12, 2019	SELL	$7.38 - $12.25 $9,985 - $16,574	-1,353 Reduced 5.27%	24,301 $179,000
Q2 2019 Aug 13, 2019	BUY	$9.35 - $11.41 $70,770 - $86,362	7,569 Added 41.85%	25,654 $288,000
Q1 2019 May 14, 2019	SELL	$9.5 - $19.16 $22,135 - $44,642	-2,330 Reduced 11.41%	18,085 $194,000
Q4 2018 Feb 05, 2019	BUY	$12.69 - $18.61 $19,859 - $29,124	1,565 Added 8.3%	20,415 $308,000
Q3 2018 Nov 14, 2018	SELL	$18.04 - $26.41 $243,251 - $356,112	-13,484 Reduced 41.7%	18,850 $349,000
Q2 2018 Aug 10, 2018	SELL	$21.38 - $29.68 $54,347 - $75,446	-2,542 Reduced 7.29%	32,334 $739,000
Q1 2018 May 14, 2018	BUY	$21.76 - $34.22 $409,457 - $643,917	18,817 Added 117.17%	34,876 $992,000
Q4 2017 Feb 14, 2018	SELL	$19.0 - $23.09 $152,342 - $185,135	-8,018 Reduced 33.3%	16,059 $339,000
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $29,793 - $40,010	2,202 Added 10.07%	24,077 $437,000
Q2 2017 Aug 14, 2017	BUY	N/A	21,875	21,875 $339,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.7M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$8.28 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$5.54 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$5.47 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$5.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$3.29 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account